With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease||St. Jude Children's Research Hospital / Linda Hendershot, PhD||Innovation Grants||2019||Tennessee|
|Saturating CRISPR gene body scans in MLL-rearranged leukemia||Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD & Lu Yang, PhD||Innovation Grants||2019||California|
|Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis||Duke University / Corinne Linardic, MD/PhD & Yarui Diao, MD/PhD||Innovation Grants||2019||North Carolina|
|Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma||Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-reya, MD||Innovation Grants||2019||Illinois|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD & A. Thomas Look, PhD||Innovation Grants||2019||Massachusetts|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Identifying targeted treatments for DICER1-associated sarcomas||Research Institute of the McGill University Health Centre / William Foulkes, MD/PhD & Sidong Huang, MD/PhD||Innovation Grants||2019||Quebec|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||University of Southern California / Meenal Mehrotra, MD/PhD & Besim Ogretmen, MD/PhD||Innovation Grants||2019||California|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD & David T. Teachey, MD||Innovation Grants||2019||New York|